Nutr Rev. 2005 Feb;63(2):65-9.

The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome.

Source

Appareil Digestif Environnement Nutrition, IFR 23, Faculté de Médecine-Pharmacie, Rouen, France.

Abstract

Patients in the intensive care unit are at high risk of glutamine depletion and subsequent complications. Several controlled studies and a meta-analysis have concluded that glutamine supplementation has beneficial effects on the clinical outcome of critically ill and surgical patients. These results may be explained by glutamine's influences on the inflammatory response, oxidative stress, cell protection, and the gut barrier. In addition, glutamine may also improve glucose metabolism by reducing insulin resistance.

PMID:: 15762090; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Glutamine

LinkOut - more resources

Full Text Sources

Medical

ClinicalTrials.gov

Supplemental Content

Save items

Related citations in PubMed

Review Glutamine: mode of action in critical illness. [Crit Care Med. 2007]
Review Glutamine: mode of action in critical illness.
Wischmeyer PE. Crit Care Med. 2007 Sep; 35(9 Suppl):S541-4.
Review Glutamine: role in critical illness and ongoing clinical trials. [Curr Opin Gastroenterol. 2008]
Review Glutamine: role in critical illness and ongoing clinical trials.
Wischmeyer PE. Curr Opin Gastroenterol. 2008 Mar; 24(2):190-7.
Review Role of L-glutamine in critical illness: new insights. [Curr Opin Clin Nutr Metab Care...]
Review Role of L-glutamine in critical illness: new insights.
Kelly D, Wischmeyer PE. Curr Opin Clin Nutr Metab Care. 2003 Mar; 6(2):217-22.
Review REducing Deaths due to OXidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. [Proc Nutr Soc. 2006]
Review REducing Deaths due to OXidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients.
Heyland DK, Dhaliwal R, Day AG, Muscedere J, Drover J, Suchner U, Cook D, Canadian Critical Care Trials Group. Proc Nutr Soc. 2006 Aug; 65(3):250-63.
Review Glucose control in the intensive care unit. [Crit Care Med. 2009]
Review Glucose control in the intensive care unit.
Fahy BG, Sheehy AM, Coursin DB. Crit Care Med. 2009 May; 37(5):1769-76.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

The role of glutamine in intensive care unit patients: mechanisms of action and ...
The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome.
Nutr Rev. 2005 Feb ;63(2):65-9.

PubMed
Fish consumption: recommendations versus advisories, can they be reconciled?
Fish consumption: recommendations versus advisories, can they be reconciled?
Nutr Rev. 2005 Feb ;63(2):39-46.

PubMed
Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up St...
Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study.
Eur Arch Psychiatry Clin Neurosci. 1992 ;241(4):247-58.

PubMed
The Zurich Study. XII. Sex differences in depression. Evidence from longitudinal...
The Zurich Study. XII. Sex differences in depression. Evidence from longitudinal epidemiological data.
Eur Arch Psychiatry Clin Neurosci. 1992 ;241(4):222-30.

PubMed
Evidence of a polyclonal nature of myositis ossificans.
Evidence of a polyclonal nature of myositis ossificans.
Virchows Arch. 2005 Apr ;446(4):438-41. Epub 2005 Mar 11 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: